HistCite - The Kidney Transplant Papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
901	943 JOHNSON RWG CYCLOSPORINE IN CADAVERIC RENAL-TRANSPLANTATION - 3-YEAR FOLLOW-UP OF A EUROPEAN MULTICENTER TRIAL TRANSPLANTATION PROCEEDINGS. 1986 OCT; 18 (5): 1229-1233	3	13	2	6
902	973 GORDON RD, Tzakis AG, IWATSUKI S, TODO S, ESQUIVEL CO, et al. EXPERIENCE WITH ORTHOCLONE OKT3 MONOCLONAL-ANTIBODY IN LIVER- TRANSPLANTATION AMERICAN JOURNAL OF KIDNEY DISEASES. 1988 FEB; 11 (2): 141-144	3	33	2	8
903	1031 YOSHIMURA N, OKA T FK-506, A NEW IMMUNOSUPPRESSIVE AGENT - A REVIEW EOS-RIVISTA DI IMMUNOLOGIA ED IMMUNOFARMACOLOGIA. 1990; 10 (1): 32-36	3	17	4	37
904	1078 WASIK M, STEPIENSOPNIEWSKA B, LAGODZINSKI Z, GORSKI A EFFECTS OF FK-506 AND CYCLOSPORINE ON HUMAN T-LYMPHOPROLIFERATIVE AND B-LYMPHOPROLIFERATIVE RESPONSES IMMUNOPHARMACOLOGY. 1990 JUL-AUG; 20 (1): 57-61	3	15	2	11
905	1085 MURASE N, LIEBERMAN I, NALESNIK M, MINTZ D, TODO S, et al. PREVENTION OF SPONTANEOUS DIABETES IN BB RATS WITH FK-506 LANCET. 1990 AUG 11; 336 (8711): 373-374	3	10	1	9
906	1091 LI PKT, NICHOLLS MG, LAI KN THE COMPLICATIONS OF NEWER TRANSPLANT ANTIREJECTION DRUGS - TREATMENT WITH CYCLOSPORINE-A, OKT3, AND FK-506 ADVERSE DRUG REACTIONS AND TOXICOLOGICAL REVIEWS. 1990 FAL; 9 (3): 123-155	3	16	12	196
907	1127 LOMBARDI T, FIOREDONNO G, BELSER U, DIFELICE R FELODIPINE-INDUCED GINGIVAL HYPERPLASIA - A CLINICAL AND HISTOLOGIC-STUDY JOURNAL OF ORAL PATHOLOGY & MEDICINE. 1991 FEB; 20 (2): 89-92	3	30	3	44
908	1132 MURASE N, LIEBERMAN I, NALESNIK M, MINTZ D, TODO S, et al. FK-506 PREVENTS SPONTANEOUS DIABETES IN THE BB RAT TRANSPLANTATION PROCEEDINGS. 1991 FEB; 23 (1): 551-555	3	5	4	25
909	1149 PAINTAUD G, MIGUET JP DIAGNOSTIC-TOOLS IN LIVER ALLOGRAFT-REJECTION JOURNAL OF HEPATOLOGY. 1991 MAR; 12 (2): 256-260	3	5	1	57
910	1150 BAUMANN G, GEISSE S, SULLIVAN M CYCLOSPORINE-A AND FK-506 BOTH AFFECT DNA-BINDING OF REGULATORY NUCLEAR PROTEINS TO THE HUMAN INTERLEUKIN-2 PROMOTER NEW BIOLOGIST. 1991 MAR; 3 (3): 270-278	3	24	2	50
#	Date / Author / Journal	LCS	GCS	LCR	CR
911	1151 HEITMAN J, MOVVA NR, HIESTAND PC, HALL MN FK-506-BINDING PROTEIN PROLINE ROTAMASE IS A TARGET FOR THE IMMUNOSUPPRESSIVE AGENT FK-506 IN SACCHAROMYCES-CEREVISIAE PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 1991 MAR; 88 (5): 1948-1952	3	208	5	52
912	1192 WHITING PH, WOO J, ADAM BJ, HASAN NU, DAVIDSON RJL, et al. TOXICITY OF RAPAMYCIN - A COMPARATIVE AND COMBINATION STUDY WITH CYCLOSPORINE AT IMMUNOTHERAPEUTIC DOSAGE IN THE RAT TRANSPLANTATION. 1991 AUG; 52 (2): 203-208	3	75	6	36
913	1194 SIMMONS RL, WANG SC NEW HORIZONS IN IMMUNOSUPPRESSION TRANSPLANTATION PROCEEDINGS. 1991 AUG; 23 (4): 2152-2156	3	11	5	70
914	1229 FELSER I, WAGNER S, DEPEE J, JOHNSON N, STASCHAK S, et al. CHANGES IN QUALITY-OF-LIFE FOLLOWING CONVERSION FROM CYA TO FK-506 IN ORTHOTOPIC LIVER-TRANSPLANT PATIENTS TRANSPLANTATION PROCEEDINGS. 1991 DEC; 23 (6): 3032-3034	3	9	2	3
915	1233 DARRAS FS, JORDAN ML, SHAPIRO R, SUNDBERG R, SCANTLEBURY VP, et al. TRANSPLANTATION OF PEDIATRIC EN-BLOC KIDNEYS UNDER FK-506 IMMUNOSUPPRESSION TRANSPLANTATION PROCEEDINGS. 1991 DEC; 23 (6): 3089-3090	3	10	2	5
916	1236 PERICO N, AMUCHASTEGUI CS, ZOJA C, BENIGNI A, MORIGI M, et al. FK-506 DOES NOT AFFECT THE GLOMERULAR-FILTRATION RATE AND RENAL PLASMA-FLOW IN THE RAT TRANSPLANTATION PROCEEDINGS. 1991 DEC; 23 (6): 3123-3125	3	13	6	18
917	1244 OHTSUKA S, HAYASHI S, SATO E, TANAKA Y, HACHISUKA T, et al. THE EFFECT OF SHORT-TERM FK-506 THERAPY ON PANCREAS TRANSPLANTATION IN RATS TRANSPLANTATION PROCEEDINGS. 1991 DEC; 23 (6): 3217-3218	3	7	6	21
918	1284 HIRAI T, WADA H, HASEGAWA S, INUI K, YOKOMISE H, et al. THE IMMUNOSUPPRESSIVE EFFECT OF FK-506 ON CANINE LUNG TRANSPLANTATION JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY. 1992 JUN; 103 (6): 1127-1135	3	12	5	23
919	1323 HIRANO Y, HISATOMI A, OHARA K, NOGUCHI H THE EFFECTS OF FK506 AND CYCLOSPORINE ON THE EXOCRINE FUNCTION OF THE RAT PANCREAS TRANSPLANTATION. 1992 NOV; 54 (5): 883-887	3	14	6	33
920	1356 KLINTMALM GBG, GOLDSTEIN R, GONWA T, WIESNER RH, KROM RAF, et al. PROGNOSTIC FACTORS FOR SUCCESSFUL CONVERSION FROM CYCLOSPORINE TO FK-506 - BASED IMMUNOSUPPRESSIVE THERAPY FOR REFRACTORY REJECTION AFTER LIVER-TRANSPLANTATION TRANSPLANTATION PROCEEDINGS. 1993 FEB; 25 (1): 641-643	3	8	6	11
#	Date / Author / Journal	LCS	GCS	LCR	CR
921	1357 LANE BC, MILLER LN, KAWAI M, OR YS, WIEDEMAN P, et al. EVALUATION OF CALCINEURIN ROLE IN THE IMMUNOSUPPRESSIVE ACTIVITY OF FK-506, RELATED MACROLACTAMS, AND CYCLOSPORINE TRANSPLANTATION PROCEEDINGS. 1993 FEB; 25 (1): 644-646	3	9	1	17
922	1364 TAMURA K, WOO J, MURASE N, CARRIERI G, NALESNIK MA, et al. SUPPRESSION OF AUTOIMMUNE THYROID-DISEASE BY FK-506 - INFLUENCE ON THYROID-INFILTRATING CELLS, ADHESION MOLECULE EXPRESSION AND ANTITHYROGLOBULIN ANTIBODY-PRODUCTION CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 1993 MAR; 91 (3): 368-375	3	12	6	32
923	1414 ROELEN DL, VANBREE FPMJ, SCHANZ U, VANROOD JJ, CLAAS FHJ DIFFERENTIAL INHIBITION OF PRIMED ALLOREACTIVE CTLS IN-VITRO BY CLINICALLY USED CONCENTRATIONS OF CYCLOSPORINE AND FK506 TRANSPLANTATION. 1993 JUL; 56 (1): 190-195	3	16	6	48
924	1415 KNOOP C, ANDRIEN M, ANTOINE M, LAMBERMONT M, YERNAULT JC, et al. SEVERE HEMOLYSIS DUE TO A DONOR ANTI-D ANTIBODY AFTER HEART-LUNG TRANSPLANTATION - ASSOCIATION WITH LUNG AND BLOOD CHIMERISM AMERICAN REVIEW OF RESPIRATORY DISEASE. 1993 AUG; 148 (2): 504-506	3	23	1	18
925	1420 SHAEFER MS, COLLIER DS, HAVEN MC, LANGNAS AN, STRATTA RJ, et al. FALSELY ELEVATED FK-506 LEVELS CAUSED BY SAMPLING THROUGH CENTRAL VENOUS CATHETERS TRANSPLANTATION. 1993 AUG; 56 (2): 475-476	3	5	4	17
926	1441 KAMADA N, GOTO S, KOBAYASHI E, ENOSAWA S, DELRIVIERE L, et al. RELEASE OF SOLUBLE MHC CLASS-I ANTIGENS BEFORE AND AFTER ORTHOTOPIC LIVER RETRANSPLANTATION IN THE RAT TRANSPLANTATION PROCEEDINGS. 1993 OCT; 25 (5): 2857-2857	3	5	1	4
927	1442 KAMADA N, KOBAYASHI E, DELRIVIERE L, GOTO S, LORD R, et al. MIGRATION OF CELLS ENCODED BY DONOR-TYPE MHC CLASS-I ANTIGENS AFTER LIVER-TRANSPLANTATION IN THE RAT TRANSPLANTATION PROCEEDINGS. 1993 OCT; 25 (5): 2858-2858	3	4	1	5
928	1473 RUBOCKI RJ, LANGNAS AN, SHEPHERD S, DEGENHARDT JA, CATTRAL MS, et al. THE ORIGIN OF LYMPHOCYTES IN DONOR-DERIVED LYMPH-NODES FOLLOWING COMBINED LIVER AND SMALL-BOWEL TRANSPLANTATION TRANSPLANTATION. 1994 JAN; 57 (2): 303-306	3	4	2	14
929	1483 NIKAEIN A, COLLINS RH, KLINTMALM G, POOLE T, FAY JW, et al. IMMUNOLOGICAL MONITORING OF GRAFT-VERSUS-HOST DISEASE FOLLOWING ORTHOTOPIC LIVER-TRANSPLANTATION TRANSPLANTATION. 1994 FEB 27; 57 (4): 637-640	3	6	2	15
930	1508 JULIE C, ASTARCIOGLU I, TRICOTTET V, FABIANI B, ACCORDINI C, et al. EXPRESSION OF DONOR AND RECIPIENT CLASS-I MHC ANTIGENS BY KUPFFER CELLS AFTER ORTHOTOPIC RAT-LIVER TRANSPLANTATION - AN IMMUNOELECTRON MICROSCOPIC STUDY TRANSPLANTATION. 1994 MAY 27; 57 (10): 1525-1528	3	4	2	18
#	Date / Author / Journal	LCS	GCS	LCR	CR
931	1566 KAHAN BD, GHOBRIAL R IMMUNOSUPPRESSIVE AGENTS SURGICAL CLINICS OF NORTH AMERICA. 1994 OCT; 74 (5): 1029-&	3	24	9	150
932	1573 CALNE RY IMMUNOSUPPRESSION IN LIVER-TRANSPLANTATION NEW ENGLAND JOURNAL OF MEDICINE. 1994 OCT 27; 331 (17): 1154-1155	3	17	4	13
933	1578 NUSBACHER J BLOOD-TRANSFUSION IS MONONUCLEAR CELL TRANSPLANTATION TRANSFUSION. 1994 NOV-DEC; 34 (11): 1002-1006	3	23	3	69
934	1581 KO S, NAKAJIMA Y, KANEHIRO H, YOSHIMURA A, NAKANO H THE PHARMACOKINETIC BENEFITS OF NEWLY DEVELOPED LIPOSOME-INCORPORATED FK506 TRANSPLANTATION. 1994 NOV 27; 58 (10): 1142-1144	3	17	5	14
935	1592 RAO AS, FONTES P, ZEEVI A, TRUCCO M, SHAPIRO R, et al. COMBINED BONE-MARROW AND WHOLE-ORGAN TRANSPLANTATION FROM THE SAME DONOR TRANSPLANTATION PROCEEDINGS. 1994 DEC; 26 (6): 3377-3378	3	7	5	7
936	1605 NAGANO H, TANIGAWA T, YOSHIDA T, OTA H, AKAGI K, et al. ROLE OF MICRO-CHIMERISM IN INDUCING IMMUNOLOGICAL-TOLERANCE BY INTRAPORTAL INJECTION OF DONOR SPLEEN-CELLS IN RATS CELL TRANSPLANTATION. 1995; 4: S59-S60	3	6	2	9
937	1606 TASHIRO H, FUKUDA Y, HOSHINO S, FURUKAWA M, SHINTAKU S, et al. MONITORING FOR ENGRAFTMENT FOLLOWING RAT ORTHOTOPIC LIVER-TRANSPLANTATION BY IN-VITRO AMPLIFICATION OF Y- CHROMOSOME GENE USING POLYMERASE CHAIN-REACTION CELL TRANSPLANTATION. 1995; 4: S61-S63	3	5	1	2
938	1617 ALESSIANI M, Tzakis AG, TODO S, DEMETRIS AJ, FUNG JJ, et al. ASSESSMENT OF 5-YEAR EXPERIENCE WITH ABDOMINAL ORGAN CLUSTER TRANSPLANTATION JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS. 1995 JAN; 180 (1): 1-9	3	90	6	18
939	1619 CAKALOGLU Y, DEVLIN J, OGRADY J, SUTHERLAND S, PORTMANN BC, et al. IMPORTANCE OF CONCOMITANT VIRAL-INFECTION DURING - LATE ACUTE LIVER ALLOGRAFT-REJECTION TRANSPLANTATION. 1995 JAN 15; 59 (1): 40-45	3	39	4	23
940	1620 CHENWOAN M, DELANEY CP, FOURNIER V, WAKIZAKA Y, MURASE N, et al. A NEW PROTOCOL FOR THE PROPAGATION OF DENDRITIC CELLS FROM RAT BONE- MARROW USING RECOMBINANT GM-CSF, AND THEIR QUANTIFICATION USING THE MAB OX-62 JOURNAL OF IMMUNOLOGICAL METHODS. 1995 JAN 27; 178 (2): 157-171	3	39	5	30
#	Date / Author / Journal	LCS	GCS	LCR	CR
941	1632 DEMETRIS AJ, MURASE N, DELANEY CP, WOAN M, FUNG JJ, et al. THE LIVER ALLOGRAFT, CHRONIC (DUCTOPENIC) REJECTION, AND MICROCHIMERISM - WHAT CAN THEY TEACH US TRANSPLANTATION PROCEEDINGS. 1995 FEB; 27 (1): 67-70	3	7	7	53
942	1636 MURASE N, DEMETRIS AJ, FUJISAKI S, TANABE M, QING Y, et al. BONE-MARROW AUGMENTATION FOR HEART, LIVER, AND SMALL-BOWEL TRANSPLANTATION - PROLONGATION OF GRAFT-SURVIVAL AND INCIDENCE OF GRAFT-VERSUS-HOST DISEASE TRANSPLANTATION PROCEEDINGS. 1995 FEB; 27 (1): 174-175	3	7	3	7
943	1637 LU L, RUDERT WA, NOYOLA H, QIAN S, FU F, et al. PROPAGATION OF CELLS EXPRESSING DONOR PHENOTYPE (MHC CLASS-I, CLASS-II AND Y-CHROMOSOME) FROM THE BONE-MARROW OF MURINE LIVER ALLOGRAFT RECIPIENTS IN RESPONSE TO GM-CSF IN-VITRO TRANSPLANTATION PROCEEDINGS. 1995 FEB; 27 (1): 191-193	3	4	5	9
944	1641 HISANAGA M, HUNDRIESER J, UTHOFF K, WAHLERS T, PICHLMAYR R, et al. GRAFT FUNCTION AND REJECTION PATTERNS IN HEART-TRANSPLANTED PATIENTS WITH AND WITHOUT SYSTEMIC MICROCHIMERISM TRANSPLANTATION PROCEEDINGS. 1995 FEB; 27 (1): 202-204	3	4	5	12
945	1645 ZEEVI A, PAVLICK M, LOMBARDOZZI S, BANAS R, RAO AS, et al. SERIAL EVALUATION OF IMMUNE PROFILES OF SIMULTANEOUS BONE-MARROW AND WHOLE-ORGAN TRANSPLANT RECIPIENTS TRANSPLANTATION PROCEEDINGS. 1995 FEB; 27 (1): 213-215	3	3	3	10
946	1655 WINKLER M, WONIGEIT K, UNDRE N, RINGE B, OLDHAFER K, et al. COMPARISON OF PLASMA VS WHOLE-BLOOD AS MATRIX FOR FK-506 DRUG LEVEL MONITORING TRANSPLANTATION PROCEEDINGS. 1995 FEB; 27 (1): 822-825	3	10	5	10
947	1661 LOSS M, WINKLER M, SCHNEIDER A, BRINKMANN C, MANNS M, et al. INFLUENCE OF LONG-TERM CYCLOSPORINE OR FK-506 THERAPY ON GLUCOSE AND LIPID-METABOLISM IN STABLE LIVER GRAFT RECIPIENTS TRANSPLANTATION PROCEEDINGS. 1995 FEB; 27 (1): 1136-1139	3	25	2	9
948	1662 LUM CT, UMEN AJ, KASISKE B, GOERDT P, HEIMDUTHOY KL, et al. CLINICAL IMPACT OF REPLACING MINNESOTA ANTILYMPHOCYTE GLOBULIN WITH ATGAM TRANSPLANTATION. 1995 FEB 15; 59 (3): 371-376	3	10	5	22
949	1673 DEBRUYNE LA, RENLUND DG, BISHOP DK EVIDENCE THAT HUMAN CARDIAC ALLOGRAFT ACCEPTANCE IS ASSOCIATED WITH A DECREASE IN DONOR-REACTIVE HELPER T- LYMPHOCYTES TRANSPLANTATION. 1995 MAR 15; 59 (5): 778-783	3	25	3	35
950	1677 MCDIARMID SV, WALLACE P, VARGAS J, AMENT ME, BUSUTTIL RW THE TREATMENT OF INTRACTABLE REJECTION WITH TACROLIMUS (FK506) IN PEDIATRIC LIVER-TRANSPLANT RECIPIENTS JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION. 1995 APR; 20 (3): 291-299	3	22	23	61
#	Date / Author / Journal	LCS	GCS	LCR	CR
951	1701 KANAMARU A, TAKEMOTO Y, KAKISHITA E, DOHY H, KODERA Y, et al. FK506 TREATMENT OF GRAFT-VERSUS-HOST DISEASE DEVELOPING OR EXACERBATING DURING PROPHYLAXIS AND THERAPY WITH CYCLOSPORINE AND/OR OTHER IMMUNOSUPPRESSANTS BONE MARROW TRANSPLANTATION. 1995 JUN; 15 (6): 885-889	3	45	7	16
952	1743 GONSCHIOR AK, CHRISTIANS U, WINKLER M, SCHIEBEL HM, LINCK A, et al. SIMPLIFIED HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY MASS-SPECTROMETRY ASSAY FOR MEASUREMENT OF TACROLIMUS AND ITS METABOLITES AND CROSS-VALIDATION WITH MICROPARTICLE ENZYME-IMMUNOASSAY THERAPEUTIC DRUG MONITORING. 1995 OCT; 17 (5): 504-510	3	35	13	33
953	1765 Rao AS, Fontes P, Zeevi A, Rugeles M, Shapiro R, et al. Enhancement of donor cell chimerism in whole organ allograft recipients by adjuvant bone marrow transplantation TRANSPLANTATION PROCEEDINGS. 1995 DEC; 27 (6): 3387-3388	3	6	5	6
954	1792 Delaney CP, Murase N, ChenWoan M, Fung JJ, Starzl TE, et al. Allogeneic hematolymphoid microchimerism and prevention of autoimmune disease in the rat - A relationship between allo- and autoimmunity JOURNAL OF CLINICAL INVESTIGATION. 1996 JAN 1; 97 (1): 217-225	3	11	8	53
955	1800 Wood KJ New concepts in tolerance CLINICAL TRANSPLANTATION. 1996 FEB; 10 (1): 93-99	3	17	2	47
956	1824 Hisanaga M, Schlitt HJ, Hundrieser J, Nakajima Y, Kanehiro H, et al. Donor-derived microchimerism in heart transplant recipients: A parameter for immunological risk? TRANSPLANTATION PROCEEDINGS. 1996 APR; 28 (2): 1036-1038	3	4	4	11
957	1845 Fu E, Nieh S, Chang HL, Wang SL Cyclosporin A-induced gingival overgrowth in rots: Macroscopic and microscopic observations INTERNATIONAL JOURNAL OF PERIODONTICS & RESTORATIVE DENTISTRY. 1996 JUN; 16 (3): 279-291	3	7	6	55
958	1898 Ohshima S, Fujita T, Ono Y, Kinukawa T, Katoh N, et al. Immunosuppressive treatment of primary cadaveric renal transplant patients receiving kidneys from non-heart beating donors ARTIFICIAL ORGANS. 1996 OCT; 20 (10): 1130-1136	3	8	3	14
959	1919 Platz KP, Mueller AR, Rossaint R, Steinmuller T, Lemmens HP, et al. Cytokine pattern during rejection and infection after liver transplantation - Improvements in postoperative monitoring? TRANSPLANTATION. 1996 NOV 27; 62 (10): 1441-1450	3	43	4	44
960	1955 Slakey DP, Johnson CP, Cziperle DJ, Roza AM, Wittmann DH, et al. Management of severe pancreatitis in renal transplant recipients ANNALS OF SURGERY. 1997 FEB; 225 (2): 217-222	3	17	4	20
#	Date / Author / Journal	LCS	GCS	LCR	CR
961	1993 SustentoReodica N, Ruiz P, Rogers A, Viciana AL, Conn HO, et al. Recurrent Crohn's disease in transplanted bowel LANCET. 1997 MAR 8; 349 (9053): 688-691	3	36	2	10
962	2020 Nalesnik MA, Rao AS, Furukawa H, Pham S, Zeevi A, et al. Autologous lymphokine-activated killer cell therapy of Epstein-Barr virus-positive and -negative lymphoproliferative disorders arising in organ transplant recipients TRANSPLANTATION. 1997 MAY 15; 63 (9): 1200-1205	3	75	4	43
963	2064 Legendre C, CaillatZucman S, Samuel D, Morelon S, Bismuth H, et al. Transfer of symptomatic peanut allergy to the recipient of a combined liver-and-kidney transplant NEW ENGLAND JOURNAL OF MEDICINE. 1997 SEP 18; 337 (12): 822-824	3	71	2	15
964	2071 Starzl TE, Eliasziw M, Gjertson D, Terasaki PI, Fung JJ, et al. HLA and cross-reactive antigen group matching for cadaver kidney allocation TRANSPLANTATION. 1997 OCT 15; 64 (7): 983-991	3	33	9	58
965	2084 Allen MD, Weyhrich J, Gaur L, Akimoto H, Hall J, et al. Prolonged allogeneic and xenogeneic microchimerism in unmatched primates without immunosuppression by intrathymic implantation of CD34(+) donor marrow cells CELLULAR IMMUNOLOGY. 1997 NOV 1; 181 (2): 127-138	3	11	9	64
966	2101 Shihab FS, Bennett WM, Tanner AM, Andoh TF Mechanism of fibrosis in experimental tacrolimus nephrotoxicity TRANSPLANTATION. 1997 DEC 27; 64 (12): 1829-1837	3	64	7	58
967	2120 Miles AMV, Sumrani N, Horwitz R, Homel P, Maursky V, et al. Diabetes mellitus after renal transplantation - As deleterious as non-transplant-associated diabetes? TRANSPLANTATION. 1998 FEB 15; 65 (3): 380-384	3	152	8	27
968	2140 Platt JL New directions for organ transplantation NATURE. 1998 APR 30; 392 (6679): 11-17	3	149	2	56
969	2168 Martin SR, Paradis K, Alvarez F Cyclosporine monotherapy in long-term pediatric liver transplant recipients TRANSPLANTATION PROCEEDINGS. 1998 JUN; 30 (4): 1424-1426	3	6	5	16
970	2245 Mathurin P, Mouquet C, Poynard T, Sylla C, Benalia H, et al. Impact of hepatitis B and C virus on kidney transplantation outcome HEPATOLOGY. 1999 JAN; 29 (1): 257-263	3	270	3	34
#	Date / Author / Journal	LCS	GCS	LCR	CR
971	2261 Monaco AP Antilymphocyte serum, donor bone marrow and tolerance to allografts: The journey is the reward TRANSPLANTATION PROCEEDINGS. 1999 FEB-MAR; 31 (1-2): 67-71	3	9	6	51
972	2275 Gammie JS, Pham SM Simultaneous donor bone marrow and cardiac transplantation: Can tolerance be induced with the development of chimerism? CURRENT OPINION IN CARDIOLOGY. 1999 MAR; 14 (2): 126-132	3	8	13	52
973	2279 Hebert MF, Ascher NL, Lake JR, Emond J, Nikolai B, et al. Four-year follow-up of mycophenolate mofetil for graft rescue in liver allograft recipients. TRANSPLANTATION. 1999 MAR 15; 67 (5): 707-712	3	50	2	12
974	2295 Inman B, Halloran B, Melk A, Ramassar V, Halloran PF Microchimerism in sensitized renal patients TRANSPLANTATION. 1999 MAY 27; 67 (10): 1381-1383	3	10	4	12
975	2301 Kur F, Reichenspurner H, Meiser BM, Welz A, Furst H, et al. Tacrolismus (FK506) as primary immunosuppressant after lung transplantation THORACIC AND CARDIOVASCULAR SURGEON. 1999 JUN; 47 (3): 174-178	3	24	7	20
976	2312 Fuchimoto Y, Huang C, Shimizu A, Seebach J, Arn S, et al. An allelic non-histocompatibility antigen with wide tissue distribution as a marker for chimerism in pigs TISSUE ANTIGENS. 1999 JUL; 54 (1): 43-52	3	27	4	20
977	2337 Zhang J, Tong KL, Li PKT, Chan AYW, Yeung CK, et al. Presence of donor- and recipient-derived DNA in cell-free urine samples of renal transplantation recipients: Urinary DNA chimerism CLINICAL CHEMISTRY. 1999 OCT; 45 (10): 1741-1746	3	34	12	29
978	2372 Starzl TE, Murase N, Demetris A, Trucco M, Fung JJ The mystique of hepatic tolerogenicity SEMINARS IN LIVER DISEASE. 2000; 20 (4): 497-510	3	14	50	140
979	2488 Feng FY, Ogden MA, Myckatyn TM, Grand AG, Jensen JN, et al. FK506 rescues peripheral nerve allografts in acute rejection JOURNAL OF NEUROTRAUMA. 2001 FEB; 18 (2): 217-229	3	28	9	65
980	2497 Ringe B, Braun F, Schutz E, Fuzesi L, Lorf T, et al. A novel management strategy of steroid-free immunosuppression after liver transplantation: Efficacy and safety of tacrolimus and mycophenolate mofetil TRANSPLANTATION. 2001 FEB 27; 71 (4): 508-515	3	49	6	39
#	Date / Author / Journal	LCS	GCS	LCR	CR
981	2531 Hiraoka A, Ohashi Y, Okamoto S, Moriyama Y, Nagao T, et al. Phase III study comparing tacrolimus (FK506) with cyclosporine for graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation BONE MARROW TRANSPLANTATION. 2001 JUL; 28 (2): 181-185	3	52	3	18
982	2545 Baker RJ, Hernandez-Fuentes MP, Brookes PA, Chaudhry AN, Lechler RI The role of the allograft in the induction of donor-specific T cell hyporesponsiveness TRANSPLANTATION. 2001 AUG 15; 72 (3): 480-485	3	30	4	37
983	2562 Rogers J, Bueno J, Shapiro R, Scantlebury V, Mazariegos G, et al. Results of simultaneous and sequential pediatric liver and kidney transplantation TRANSPLANTATION. 2001 NOV 27; 72 (10): 1666-1670	3	16	6	15
984	2569 Lerut JR, Ciccarelli O, Mauel E, Gheerardhyn R, Talpe S, et al. Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study TRANSPLANT INTERNATIONAL. 2001 DEC; 14 (6): 420-428	3	14	9	55
985	2600 Coates PTH, Thomson AW Dendritic cells, tolerance induction and transplant outcome AMERICAN JOURNAL OF TRANSPLANTATION. 2002 APR; 2 (4): 299-307	3	36	17	68
986	2624 Rotrosen D, Matthews JB, Bluestone JA The immune tolerance network: A new paradigm for developing tolerance-inducing therapies JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2002 JUL; 110 (1): 17-23	3	20	4	29
987	2647 Demetris AJ, Ruppert K, Dvorchik I, Jain A, Minervini M, et al. Real-time monitoring of acute liver-allograft rejection using the Banff schema TRANSPLANTATION. 2002 NOV 15; 74 (9): 1290-1296	3	34	13	64
988	2648 Opelz G, Margreiter R, Dohler B Prolongation of long-term kidney graft survival by a simultaneous liver transplant: The liver does it, and the heart does it too TRANSPLANTATION. 2002 NOV 27; 74 (10): 1390-1394	3	20	4	17
989	2665 Lo CM, Fung JTK, Lau GKK, Liu CL, Cheung ST, et al. Development of antibody to hepatitis B surface antigen after liver transplantation for chronic hepatitis B HEPATOLOGY. 2003 JAN; 37 (1): 36-43	3	42	6	35
990	2705 Nakao A, Nalesnik MA, Ishikawa T, Azhipa O, Demetris AJ, et al. Chimerism and tolerance in rat recipients of intestinal allografts from ALS-treated donors with and without adjunct naive-donor-strain bone-marrow cells TRANSPLANTATION. 2003 MAY 15; 75 (9): 1575-1581	3	6	9	26
#	Date / Author / Journal	LCS	GCS	LCR	CR
991	2720 Wu T, Cieply K, Nalesnik MA, Randhawa PS, Sonzogni A, et al. Minimal evidence of transdifferentiation from recipient bone marrow to parenchymal cells in regenerating and long-surviving human allografts AMERICAN JOURNAL OF TRANSPLANTATION. 2003 SEP; 3 (9): 1173-1181	3	24	5	38
992	2723 Kadry Z, Mullhaupt B, Renner EL, Bauerfeind P, Schanz U, et al. Living donor liver transplantation and tolerance: A potential strategy in cholangiocarcinoma TRANSPLANTATION. 2003 SEP 27; 76 (6): 1003-1006	3	28	3	20
993	2732 Muramatsu K, Kurokawa Y, Ihara K, Sakamoto S, Song YX, et al. Behavior of male-specific minor histocompatibility antigen in skin and limb transplantation JOURNAL OF SURGICAL RESEARCH. 2003 NOV; 115 (1): 106-112	3	8	3	27
994	2740 McDiarmid SV Current status of liver transplantation in children PEDIATRIC CLINICS OF NORTH AMERICA. 2003 DEC; 50 (6): 1335-+	3	33	11	265
995	2747 Gold BG, Zhong YP FK506 requires stimulation of the extracellular signal-regulated kinase 1/2 and the steroid receptor chaperone protein p23 for neurite elongation NEUROSIGNALS. 2004; 13 (3): 122-129	3	17	9	61
996	2755 Walling HW, Voigt MD, Stone MS Lichenoid graft vs. host disease following liver transplantation JOURNAL OF CUTANEOUS PATHOLOGY. 2004 FEB; 31 (2): 179-184	3	7	6	36
997	2778 Demetris AJ, Eghtesad B, Marcos A, Ruppert K, Nalesnik MA, et al. Recurrent hepatitis C in liver allografts - Prospective assessment of diagnostic accuracy, identification of pitfalls, and observations about pathogenesis AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2004 MAY; 28 (5): 658-669	3	50	6	42
998	2780 Ansari MJI, Sayegh MH Clinical transplantation tolerance: The promise and challenges KIDNEY INTERNATIONAL. 2004 MAY; 65 (5): 1560-1563	3	16	10	47
999	2807 Utter GH, Owings JT, Lee TH, Paglieroni TG, Reed WF, et al. Blood transfusion is associated with donor leukocyte microchimerism in trauma patients JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE. 2004 OCT; 57 (4): 702-707	3	28	4	25
1000	2834 Bond GJ, Mazariegos GV, Sindhi R, Abu-Elmagd KM, Reyes J Evolutionary experience with immunosuppression in pediatric intestinal transplantation JOURNAL OF PEDIATRIC SURGERY. 2005 JAN; 40 (1): 274-279	3	22	12	34

Date / Author / Journal

901

CYCLOSPORINE IN CADAVERIC RENAL-TRANSPLANTATION - 3-YEAR FOLLOW-UP OF A EUROPEAN MULTICENTER TRIAL

TRANSPLANTATION PROCEEDINGS. 1986 OCT; 18 (5): 1229-1233

902

973 GORDON RD, Tzakis AG, IWATSUKI S, TODO S, ESQUIVEL CO, et al.

EXPERIENCE WITH ORTHOCLONE OKT3 MONOCLONAL-ANTIBODY IN LIVER- TRANSPLANTATION

AMERICAN JOURNAL OF KIDNEY DISEASES. 1988 FEB; 11 (2): 141-144

903

1031 YOSHIMURA N, OKA T

FK-506, A NEW IMMUNOSUPPRESSIVE AGENT - A REVIEW

EOS-RIVISTA DI IMMUNOLOGIA ED IMMUNOFARMACOLOGIA. 1990; 10 (1): 32-36

904

1078 WASIK M, STEPIENSOPNIEWSKA B, LAGODZINSKI Z, GORSKI A

EFFECTS OF FK-506 AND CYCLOSPORINE ON HUMAN T-LYMPHOPROLIFERATIVE AND B-LYMPHOPROLIFERATIVE RESPONSES

IMMUNOPHARMACOLOGY. 1990 JUL-AUG; 20 (1): 57-61

905

1085 MURASE N, LIEBERMAN I, NALESNIK M, MINTZ D, TODO S, et al.

PREVENTION OF SPONTANEOUS DIABETES IN BB RATS WITH FK-506

LANCET. 1990 AUG 11; 336 (8711): 373-374

906

1091 LI PKT, NICHOLLS MG, LAI KN

THE COMPLICATIONS OF NEWER TRANSPLANT ANTIREJECTION DRUGS - TREATMENT WITH CYCLOSPORINE-A, OKT3, AND FK-506

ADVERSE DRUG REACTIONS AND TOXICOLOGICAL REVIEWS. 1990 FAL; 9 (3): 123-155

196

907

1127 LOMBARDI T, FIOREDONNO G, BELSER U, DIFELICE R

FELODIPINE-INDUCED GINGIVAL HYPERPLASIA - A CLINICAL AND HISTOLOGIC-STUDY

JOURNAL OF ORAL PATHOLOGY & MEDICINE. 1991 FEB; 20 (2): 89-92

908

1132 MURASE N, LIEBERMAN I, NALESNIK M, MINTZ D, TODO S, et al.

FK-506 PREVENTS SPONTANEOUS DIABETES IN THE BB RAT

TRANSPLANTATION PROCEEDINGS. 1991 FEB; 23 (1): 551-555

909

1149 PAINTAUD G, MIGUET JP

DIAGNOSTIC-TOOLS IN LIVER ALLOGRAFT-REJECTION

JOURNAL OF HEPATOLOGY. 1991 MAR; 12 (2): 256-260

910

1150 BAUMANN G, GEISSE S, SULLIVAN M

CYCLOSPORINE-A AND FK-506 BOTH AFFECT DNA-BINDING OF REGULATORY NUCLEAR PROTEINS TO THE HUMAN INTERLEUKIN-2 PROMOTER

NEW BIOLOGIST. 1991 MAR; 3 (3): 270-278

Date / Author / Journal

LCS

GCS

LCR

911

1151 HEITMAN J, MOVVA NR, HIESTAND PC, HALL MN

FK-506-BINDING PROTEIN PROLINE ROTAMASE IS A TARGET FOR THE IMMUNOSUPPRESSIVE AGENT FK-506 IN SACCHAROMYCES-CEREVISIAE

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 1991 MAR; 88 (5): 1948-1952

208

912

1192 WHITING PH, WOO J, ADAM BJ, HASAN NU, DAVIDSON RJL, et al.

TOXICITY OF RAPAMYCIN - A COMPARATIVE AND COMBINATION STUDY WITH CYCLOSPORINE AT IMMUNOTHERAPEUTIC DOSAGE IN THE RAT

TRANSPLANTATION. 1991 AUG; 52 (2): 203-208

913

1194 SIMMONS RL, WANG SC

NEW HORIZONS IN IMMUNOSUPPRESSION

TRANSPLANTATION PROCEEDINGS. 1991 AUG; 23 (4): 2152-2156

914

1229 FELSER I, WAGNER S, DEPEE J, JOHNSON N, STASCHAK S, et al.

CHANGES IN QUALITY-OF-LIFE FOLLOWING CONVERSION FROM CYA TO FK-506 IN ORTHOTOPIC LIVER-TRANSPLANT PATIENTS

TRANSPLANTATION PROCEEDINGS. 1991 DEC; 23 (6): 3032-3034

915

1233 DARRAS FS, JORDAN ML, SHAPIRO R, SUNDBERG R, SCANTLEBURY VP, et al.

TRANSPLANTATION OF PEDIATRIC EN-BLOC KIDNEYS UNDER FK-506 IMMUNOSUPPRESSION

TRANSPLANTATION PROCEEDINGS. 1991 DEC; 23 (6): 3089-3090

916

1236 PERICO N, AMUCHASTEGUI CS, ZOJA C, BENIGNI A, MORIGI M, et al.

FK-506 DOES NOT AFFECT THE GLOMERULAR-FILTRATION RATE AND RENAL PLASMA-FLOW IN THE RAT

TRANSPLANTATION PROCEEDINGS. 1991 DEC; 23 (6): 3123-3125

917

1244 OHTSUKA S, HAYASHI S, SATO E, TANAKA Y, HACHISUKA T, et al.

THE EFFECT OF SHORT-TERM FK-506 THERAPY ON PANCREAS TRANSPLANTATION IN RATS

TRANSPLANTATION PROCEEDINGS. 1991 DEC; 23 (6): 3217-3218

918

1284 HIRAI T, WADA H, HASEGAWA S, INUI K, YOKOMISE H, et al.

THE IMMUNOSUPPRESSIVE EFFECT OF FK-506 ON CANINE LUNG TRANSPLANTATION

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY. 1992 JUN; 103 (6): 1127-1135

919

1323 HIRANO Y, HISATOMI A, OHARA K, NOGUCHI H

THE EFFECTS OF FK506 AND CYCLOSPORINE ON THE EXOCRINE FUNCTION OF THE RAT PANCREAS

TRANSPLANTATION. 1992 NOV; 54 (5): 883-887

920

1356 KLINTMALM GBG, GOLDSTEIN R, GONWA T, WIESNER RH, KROM RAF, et al.

PROGNOSTIC FACTORS FOR SUCCESSFUL CONVERSION FROM CYCLOSPORINE TO FK-506 - BASED IMMUNOSUPPRESSIVE THERAPY FOR REFRACTORY REJECTION AFTER LIVER-TRANSPLANTATION

TRANSPLANTATION PROCEEDINGS. 1993 FEB; 25 (1): 641-643

Date / Author / Journal

LCS

GCS

LCR

921

1357 LANE BC, MILLER LN, KAWAI M, OR YS, WIEDEMAN P, et al.

EVALUATION OF CALCINEURIN ROLE IN THE IMMUNOSUPPRESSIVE ACTIVITY OF FK-506, RELATED MACROLACTAMS, AND CYCLOSPORINE

TRANSPLANTATION PROCEEDINGS. 1993 FEB; 25 (1): 644-646

922

1364 TAMURA K, WOO J, MURASE N, CARRIERI G, NALESNIK MA, et al.

SUPPRESSION OF AUTOIMMUNE THYROID-DISEASE BY FK-506 - INFLUENCE ON THYROID-INFILTRATING CELLS, ADHESION MOLECULE EXPRESSION AND ANTITHYROGLOBULIN ANTIBODY-PRODUCTION

CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 1993 MAR; 91 (3): 368-375

923

1414 ROELEN DL, VANBREE FPMJ, SCHANZ U, VANROOD JJ, CLAAS FHJ

DIFFERENTIAL INHIBITION OF PRIMED ALLOREACTIVE CTLS IN-VITRO BY CLINICALLY USED CONCENTRATIONS OF CYCLOSPORINE AND FK506

TRANSPLANTATION. 1993 JUL; 56 (1): 190-195

924

1415 KNOOP C, ANDRIEN M, ANTOINE M, LAMBERMONT M, YERNAULT JC, et al.

SEVERE HEMOLYSIS DUE TO A DONOR ANTI-D ANTIBODY AFTER HEART-LUNG TRANSPLANTATION - ASSOCIATION WITH LUNG AND BLOOD CHIMERISM

AMERICAN REVIEW OF RESPIRATORY DISEASE. 1993 AUG; 148 (2): 504-506

925

1420 SHAEFER MS, COLLIER DS, HAVEN MC, LANGNAS AN, STRATTA RJ, et al.

FALSELY ELEVATED FK-506 LEVELS CAUSED BY SAMPLING THROUGH CENTRAL VENOUS CATHETERS

TRANSPLANTATION. 1993 AUG; 56 (2): 475-476

926

1441 KAMADA N, GOTO S, KOBAYASHI E, ENOSAWA S, DELRIVIERE L, et al.

RELEASE OF SOLUBLE MHC CLASS-I ANTIGENS BEFORE AND AFTER ORTHOTOPIC LIVER RETRANSPLANTATION IN THE RAT

TRANSPLANTATION PROCEEDINGS. 1993 OCT; 25 (5): 2857-2857

927

1442 KAMADA N, KOBAYASHI E, DELRIVIERE L, GOTO S, LORD R, et al.

MIGRATION OF CELLS ENCODED BY DONOR-TYPE MHC CLASS-I ANTIGENS AFTER LIVER-TRANSPLANTATION IN THE RAT

TRANSPLANTATION PROCEEDINGS. 1993 OCT; 25 (5): 2858-2858

928

1473 RUBOCKI RJ, LANGNAS AN, SHEPHERD S, DEGENHARDT JA, CATTRAL MS, et al.

THE ORIGIN OF LYMPHOCYTES IN DONOR-DERIVED LYMPH-NODES FOLLOWING COMBINED LIVER AND SMALL-BOWEL TRANSPLANTATION

TRANSPLANTATION. 1994 JAN; 57 (2): 303-306

929

1483 NIKAEIN A, COLLINS RH, KLINTMALM G, POOLE T, FAY JW, et al.

IMMUNOLOGICAL MONITORING OF GRAFT-VERSUS-HOST DISEASE FOLLOWING ORTHOTOPIC LIVER-TRANSPLANTATION

TRANSPLANTATION. 1994 FEB 27; 57 (4): 637-640

930

1508 JULIE C, ASTARCIOGLU I, TRICOTTET V, FABIANI B, ACCORDINI C, et al.

EXPRESSION OF DONOR AND RECIPIENT CLASS-I MHC ANTIGENS BY KUPFFER CELLS AFTER ORTHOTOPIC RAT-LIVER TRANSPLANTATION - AN IMMUNOELECTRON MICROSCOPIC STUDY

TRANSPLANTATION. 1994 MAY 27; 57 (10): 1525-1528

Date / Author / Journal

LCS

GCS

LCR

931

1566 KAHAN BD, GHOBRIAL R

IMMUNOSUPPRESSIVE AGENTS

SURGICAL CLINICS OF NORTH AMERICA. 1994 OCT; 74 (5): 1029-&

150

932

1573 CALNE RY

IMMUNOSUPPRESSION IN LIVER-TRANSPLANTATION

NEW ENGLAND JOURNAL OF MEDICINE. 1994 OCT 27; 331 (17): 1154-1155

933

1578 NUSBACHER J

BLOOD-TRANSFUSION IS MONONUCLEAR CELL TRANSPLANTATION

TRANSFUSION. 1994 NOV-DEC; 34 (11): 1002-1006

934

1581 KO S, NAKAJIMA Y, KANEHIRO H, YOSHIMURA A, NAKANO H

THE PHARMACOKINETIC BENEFITS OF NEWLY DEVELOPED LIPOSOME-INCORPORATED FK506

TRANSPLANTATION. 1994 NOV 27; 58 (10): 1142-1144

935

1592 RAO AS, FONTES P, ZEEVI A, TRUCCO M, SHAPIRO R, et al.

COMBINED BONE-MARROW AND WHOLE-ORGAN TRANSPLANTATION FROM THE SAME DONOR

TRANSPLANTATION PROCEEDINGS. 1994 DEC; 26 (6): 3377-3378

936

1605 NAGANO H, TANIGAWA T, YOSHIDA T, OTA H, AKAGI K, et al.

ROLE OF MICRO-CHIMERISM IN INDUCING IMMUNOLOGICAL-TOLERANCE BY INTRAPORTAL INJECTION OF DONOR SPLEEN-CELLS IN RATS

CELL TRANSPLANTATION. 1995; 4: S59-S60

937

1606 TASHIRO H, FUKUDA Y, HOSHINO S, FURUKAWA M, SHINTAKU S, et al.

MONITORING FOR ENGRAFTMENT FOLLOWING RAT ORTHOTOPIC LIVER-TRANSPLANTATION BY IN-VITRO AMPLIFICATION OF Y- CHROMOSOME GENE USING POLYMERASE CHAIN-REACTION

CELL TRANSPLANTATION. 1995; 4: S61-S63

938

1617 ALESSIANI M, Tzakis AG, TODO S, DEMETRIS AJ, FUNG JJ, et al.

ASSESSMENT OF 5-YEAR EXPERIENCE WITH ABDOMINAL ORGAN CLUSTER TRANSPLANTATION

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS. 1995 JAN; 180 (1): 1-9

939

1619 CAKALOGLU Y, DEVLIN J, OGRADY J, SUTHERLAND S, PORTMANN BC, et al.

IMPORTANCE OF CONCOMITANT VIRAL-INFECTION DURING - LATE ACUTE LIVER ALLOGRAFT-REJECTION

TRANSPLANTATION. 1995 JAN 15; 59 (1): 40-45

940

1620 CHENWOAN M, DELANEY CP, FOURNIER V, WAKIZAKA Y, MURASE N, et al.

A NEW PROTOCOL FOR THE PROPAGATION OF DENDRITIC CELLS FROM RAT BONE- MARROW USING RECOMBINANT GM-CSF, AND THEIR QUANTIFICATION USING THE MAB OX-62

JOURNAL OF IMMUNOLOGICAL METHODS. 1995 JAN 27; 178 (2): 157-171

Date / Author / Journal

LCS

GCS

LCR

941

1632 DEMETRIS AJ, MURASE N, DELANEY CP, WOAN M, FUNG JJ, et al.

THE LIVER ALLOGRAFT, CHRONIC (DUCTOPENIC) REJECTION, AND MICROCHIMERISM - WHAT CAN THEY TEACH US

TRANSPLANTATION PROCEEDINGS. 1995 FEB; 27 (1): 67-70

942

1636 MURASE N, DEMETRIS AJ, FUJISAKI S, TANABE M, QING Y, et al.

BONE-MARROW AUGMENTATION FOR HEART, LIVER, AND SMALL-BOWEL TRANSPLANTATION - PROLONGATION OF GRAFT-SURVIVAL AND INCIDENCE OF GRAFT-VERSUS-HOST DISEASE

TRANSPLANTATION PROCEEDINGS. 1995 FEB; 27 (1): 174-175

943

1637 LU L, RUDERT WA, NOYOLA H, QIAN S, FU F, et al.

PROPAGATION OF CELLS EXPRESSING DONOR PHENOTYPE (MHC CLASS-I, CLASS-II AND Y-CHROMOSOME) FROM THE BONE-MARROW OF MURINE LIVER ALLOGRAFT RECIPIENTS IN RESPONSE TO GM-CSF IN-VITRO

TRANSPLANTATION PROCEEDINGS. 1995 FEB; 27 (1): 191-193

944

1641 HISANAGA M, HUNDRIESER J, UTHOFF K, WAHLERS T, PICHLMAYR R, et al.

GRAFT FUNCTION AND REJECTION PATTERNS IN HEART-TRANSPLANTED PATIENTS WITH AND WITHOUT SYSTEMIC MICROCHIMERISM

TRANSPLANTATION PROCEEDINGS. 1995 FEB; 27 (1): 202-204

945

1645 ZEEVI A, PAVLICK M, LOMBARDOZZI S, BANAS R, RAO AS, et al.

SERIAL EVALUATION OF IMMUNE PROFILES OF SIMULTANEOUS BONE-MARROW AND WHOLE-ORGAN TRANSPLANT RECIPIENTS

TRANSPLANTATION PROCEEDINGS. 1995 FEB; 27 (1): 213-215

946

1655 WINKLER M, WONIGEIT K, UNDRE N, RINGE B, OLDHAFER K, et al.

COMPARISON OF PLASMA VS WHOLE-BLOOD AS MATRIX FOR FK-506 DRUG LEVEL MONITORING

TRANSPLANTATION PROCEEDINGS. 1995 FEB; 27 (1): 822-825

947

1661 LOSS M, WINKLER M, SCHNEIDER A, BRINKMANN C, MANNS M, et al.

INFLUENCE OF LONG-TERM CYCLOSPORINE OR FK-506 THERAPY ON GLUCOSE AND LIPID-METABOLISM IN STABLE LIVER GRAFT RECIPIENTS

TRANSPLANTATION PROCEEDINGS. 1995 FEB; 27 (1): 1136-1139

948

1662 LUM CT, UMEN AJ, KASISKE B, GOERDT P, HEIMDUTHOY KL, et al.

CLINICAL IMPACT OF REPLACING MINNESOTA ANTILYMPHOCYTE GLOBULIN WITH ATGAM

TRANSPLANTATION. 1995 FEB 15; 59 (3): 371-376

949

1673 DEBRUYNE LA, RENLUND DG, BISHOP DK

EVIDENCE THAT HUMAN CARDIAC ALLOGRAFT ACCEPTANCE IS ASSOCIATED WITH A DECREASE IN DONOR-REACTIVE HELPER T- LYMPHOCYTES

TRANSPLANTATION. 1995 MAR 15; 59 (5): 778-783

950

1677 MCDIARMID SV, WALLACE P, VARGAS J, AMENT ME, BUSUTTIL RW

THE TREATMENT OF INTRACTABLE REJECTION WITH TACROLIMUS (FK506) IN PEDIATRIC LIVER-TRANSPLANT RECIPIENTS

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION. 1995 APR; 20 (3): 291-299

Date / Author / Journal

LCS

GCS

LCR

951

1701 KANAMARU A, TAKEMOTO Y, KAKISHITA E, DOHY H, KODERA Y, et al.

FK506 TREATMENT OF GRAFT-VERSUS-HOST DISEASE DEVELOPING OR EXACERBATING DURING PROPHYLAXIS AND THERAPY WITH CYCLOSPORINE AND/OR OTHER IMMUNOSUPPRESSANTS

BONE MARROW TRANSPLANTATION. 1995 JUN; 15 (6): 885-889

952

1743 GONSCHIOR AK, CHRISTIANS U, WINKLER M, SCHIEBEL HM, LINCK A, et al.

SIMPLIFIED HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY MASS-SPECTROMETRY ASSAY FOR MEASUREMENT OF TACROLIMUS AND ITS METABOLITES AND CROSS-VALIDATION WITH MICROPARTICLE ENZYME-IMMUNOASSAY

THERAPEUTIC DRUG MONITORING. 1995 OCT; 17 (5): 504-510

953

1765 Rao AS, Fontes P, Zeevi A, Rugeles M, Shapiro R, et al.

Enhancement of donor cell chimerism in whole organ allograft recipients by adjuvant bone marrow transplantation

TRANSPLANTATION PROCEEDINGS. 1995 DEC; 27 (6): 3387-3388

954

1792 Delaney CP, Murase N, ChenWoan M, Fung JJ, Starzl TE, et al.

Allogeneic hematolymphoid microchimerism and prevention of autoimmune disease in the rat - A relationship between allo- and autoimmunity

JOURNAL OF CLINICAL INVESTIGATION. 1996 JAN 1; 97 (1): 217-225

955

1800 Wood KJ

New concepts in tolerance

CLINICAL TRANSPLANTATION. 1996 FEB; 10 (1): 93-99

956

1824 Hisanaga M, Schlitt HJ, Hundrieser J, Nakajima Y, Kanehiro H, et al.

Donor-derived microchimerism in heart transplant recipients: A parameter for immunological risk?

TRANSPLANTATION PROCEEDINGS. 1996 APR; 28 (2): 1036-1038

957

1845 Fu E, Nieh S, Chang HL, Wang SL

Cyclosporin A-induced gingival overgrowth in rots: Macroscopic and microscopic observations

INTERNATIONAL JOURNAL OF PERIODONTICS & RESTORATIVE DENTISTRY. 1996 JUN; 16 (3): 279-291

958

1898 Ohshima S, Fujita T, Ono Y, Kinukawa T, Katoh N, et al.

Immunosuppressive treatment of primary cadaveric renal transplant patients receiving kidneys from non-heart beating donors

ARTIFICIAL ORGANS. 1996 OCT; 20 (10): 1130-1136

959

1919 Platz KP, Mueller AR, Rossaint R, Steinmuller T, Lemmens HP, et al.

Cytokine pattern during rejection and infection after liver transplantation - Improvements in postoperative monitoring?

TRANSPLANTATION. 1996 NOV 27; 62 (10): 1441-1450

960

1955 Slakey DP, Johnson CP, Cziperle DJ, Roza AM, Wittmann DH, et al.

Management of severe pancreatitis in renal transplant recipients

ANNALS OF SURGERY. 1997 FEB; 225 (2): 217-222

Date / Author / Journal

LCS

GCS

LCR

961

1993 SustentoReodica N, Ruiz P, Rogers A, Viciana AL, Conn HO, et al.

Recurrent Crohn's disease in transplanted bowel

LANCET. 1997 MAR 8; 349 (9053): 688-691

962

2020 Nalesnik MA, Rao AS, Furukawa H, Pham S, Zeevi A, et al.

Autologous lymphokine-activated killer cell therapy of Epstein-Barr virus-positive and -negative lymphoproliferative disorders arising in organ transplant recipients

TRANSPLANTATION. 1997 MAY 15; 63 (9): 1200-1205

963

2064 Legendre C, CaillatZucman S, Samuel D, Morelon S, Bismuth H, et al.

Transfer of symptomatic peanut allergy to the recipient of a combined liver-and-kidney transplant

NEW ENGLAND JOURNAL OF MEDICINE. 1997 SEP 18; 337 (12): 822-824

964

2071 Starzl TE, Eliasziw M, Gjertson D, Terasaki PI, Fung JJ, et al.

HLA and cross-reactive antigen group matching for cadaver kidney allocation

TRANSPLANTATION. 1997 OCT 15; 64 (7): 983-991

965

2084 Allen MD, Weyhrich J, Gaur L, Akimoto H, Hall J, et al.

Prolonged allogeneic and xenogeneic microchimerism in unmatched primates without immunosuppression by intrathymic implantation of CD34(+) donor marrow cells

CELLULAR IMMUNOLOGY. 1997 NOV 1; 181 (2): 127-138

966

2101 Shihab FS, Bennett WM, Tanner AM, Andoh TF

Mechanism of fibrosis in experimental tacrolimus nephrotoxicity

TRANSPLANTATION. 1997 DEC 27; 64 (12): 1829-1837

967

2120 Miles AMV, Sumrani N, Horwitz R, Homel P, Maursky V, et al.

Diabetes mellitus after renal transplantation - As deleterious as non-transplant-associated diabetes?

TRANSPLANTATION. 1998 FEB 15; 65 (3): 380-384

152

968

2140 Platt JL

New directions for organ transplantation

NATURE. 1998 APR 30; 392 (6679): 11-17

149

969

2168 Martin SR, Paradis K, Alvarez F

Cyclosporine monotherapy in long-term pediatric liver transplant recipients

TRANSPLANTATION PROCEEDINGS. 1998 JUN; 30 (4): 1424-1426

970

2245 Mathurin P, Mouquet C, Poynard T, Sylla C, Benalia H, et al.

Impact of hepatitis B and C virus on kidney transplantation outcome

HEPATOLOGY. 1999 JAN; 29 (1): 257-263

270

Date / Author / Journal

971

Antilymphocyte serum, donor bone marrow and tolerance to allografts: The journey is the reward

TRANSPLANTATION PROCEEDINGS. 1999 FEB-MAR; 31 (1-2): 67-71

972

2275 Gammie JS, Pham SM

Simultaneous donor bone marrow and cardiac transplantation: Can tolerance be induced with the development of chimerism?

CURRENT OPINION IN CARDIOLOGY. 1999 MAR; 14 (2): 126-132

973

2279 Hebert MF, Ascher NL, Lake JR, Emond J, Nikolai B, et al.

Four-year follow-up of mycophenolate mofetil for graft rescue in liver allograft recipients.

TRANSPLANTATION. 1999 MAR 15; 67 (5): 707-712

974

2295 Inman B, Halloran B, Melk A, Ramassar V, Halloran PF

Microchimerism in sensitized renal patients

TRANSPLANTATION. 1999 MAY 27; 67 (10): 1381-1383

975

2301 Kur F, Reichenspurner H, Meiser BM, Welz A, Furst H, et al.

Tacrolismus (FK506) as primary immunosuppressant after lung transplantation

THORACIC AND CARDIOVASCULAR SURGEON. 1999 JUN; 47 (3): 174-178

976

2312 Fuchimoto Y, Huang C, Shimizu A, Seebach J, Arn S, et al.

An allelic non-histocompatibility antigen with wide tissue distribution as a marker for chimerism in pigs

TISSUE ANTIGENS. 1999 JUL; 54 (1): 43-52

977

2337 Zhang J, Tong KL, Li PKT, Chan AYW, Yeung CK, et al.

Presence of donor- and recipient-derived DNA in cell-free urine samples of renal transplantation recipients: Urinary DNA chimerism

CLINICAL CHEMISTRY. 1999 OCT; 45 (10): 1741-1746

978

2372 Starzl TE, Murase N, Demetris A, Trucco M, Fung JJ

The mystique of hepatic tolerogenicity

SEMINARS IN LIVER DISEASE. 2000; 20 (4): 497-510

140

979

2488 Feng FY, Ogden MA, Myckatyn TM, Grand AG, Jensen JN, et al.

FK506 rescues peripheral nerve allografts in acute rejection

JOURNAL OF NEUROTRAUMA. 2001 FEB; 18 (2): 217-229

980

2497 Ringe B, Braun F, Schutz E, Fuzesi L, Lorf T, et al.

A novel management strategy of steroid-free immunosuppression after liver transplantation: Efficacy and safety of tacrolimus and mycophenolate mofetil

TRANSPLANTATION. 2001 FEB 27; 71 (4): 508-515

Date / Author / Journal

LCS

GCS

LCR

981

2531 Hiraoka A, Ohashi Y, Okamoto S, Moriyama Y, Nagao T, et al.

Phase III study comparing tacrolimus (FK506) with cyclosporine for graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation

BONE MARROW TRANSPLANTATION. 2001 JUL; 28 (2): 181-185

982

2545 Baker RJ, Hernandez-Fuentes MP, Brookes PA, Chaudhry AN, Lechler RI

The role of the allograft in the induction of donor-specific T cell hyporesponsiveness

TRANSPLANTATION. 2001 AUG 15; 72 (3): 480-485

983

2562 Rogers J, Bueno J, Shapiro R, Scantlebury V, Mazariegos G, et al.

Results of simultaneous and sequential pediatric liver and kidney transplantation

TRANSPLANTATION. 2001 NOV 27; 72 (10): 1666-1670

984

2569 Lerut JR, Ciccarelli O, Mauel E, Gheerardhyn R, Talpe S, et al.

Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study

TRANSPLANT INTERNATIONAL. 2001 DEC; 14 (6): 420-428

985

2600 Coates PTH, Thomson AW

Dendritic cells, tolerance induction and transplant outcome

AMERICAN JOURNAL OF TRANSPLANTATION. 2002 APR; 2 (4): 299-307

986

2624 Rotrosen D, Matthews JB, Bluestone JA

The immune tolerance network: A new paradigm for developing tolerance-inducing therapies

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2002 JUL; 110 (1): 17-23

987

2647 Demetris AJ, Ruppert K, Dvorchik I, Jain A, Minervini M, et al.

Real-time monitoring of acute liver-allograft rejection using the Banff schema

TRANSPLANTATION. 2002 NOV 15; 74 (9): 1290-1296

988

2648 Opelz G, Margreiter R, Dohler B

Prolongation of long-term kidney graft survival by a simultaneous liver transplant: The liver does it, and the heart does it too

TRANSPLANTATION. 2002 NOV 27; 74 (10): 1390-1394

989

2665 Lo CM, Fung JTK, Lau GKK, Liu CL, Cheung ST, et al.

Development of antibody to hepatitis B surface antigen after liver transplantation for chronic hepatitis B

HEPATOLOGY. 2003 JAN; 37 (1): 36-43

990

2705 Nakao A, Nalesnik MA, Ishikawa T, Azhipa O, Demetris AJ, et al.

Chimerism and tolerance in rat recipients of intestinal allografts from ALS-treated donors with and without adjunct naive-donor-strain bone-marrow cells

TRANSPLANTATION. 2003 MAY 15; 75 (9): 1575-1581

Date / Author / Journal

LCS

GCS

LCR

991

2720 Wu T, Cieply K, Nalesnik MA, Randhawa PS, Sonzogni A, et al.

Minimal evidence of transdifferentiation from recipient bone marrow to parenchymal cells in regenerating and long-surviving human allografts

AMERICAN JOURNAL OF TRANSPLANTATION. 2003 SEP; 3 (9): 1173-1181

992

2723 Kadry Z, Mullhaupt B, Renner EL, Bauerfeind P, Schanz U, et al.

Living donor liver transplantation and tolerance: A potential strategy in cholangiocarcinoma

TRANSPLANTATION. 2003 SEP 27; 76 (6): 1003-1006

993

2732 Muramatsu K, Kurokawa Y, Ihara K, Sakamoto S, Song YX, et al.

Behavior of male-specific minor histocompatibility antigen in skin and limb transplantation

JOURNAL OF SURGICAL RESEARCH. 2003 NOV; 115 (1): 106-112

994

2740 McDiarmid SV

Current status of liver transplantation in children

PEDIATRIC CLINICS OF NORTH AMERICA. 2003 DEC; 50 (6): 1335-+

265

995

2747 Gold BG, Zhong YP

FK506 requires stimulation of the extracellular signal-regulated kinase 1/2 and the steroid receptor chaperone protein p23 for neurite elongation

NEUROSIGNALS. 2004; 13 (3): 122-129

996

2755 Walling HW, Voigt MD, Stone MS

Lichenoid graft vs. host disease following liver transplantation

JOURNAL OF CUTANEOUS PATHOLOGY. 2004 FEB; 31 (2): 179-184

997

2778 Demetris AJ, Eghtesad B, Marcos A, Ruppert K, Nalesnik MA, et al.

Recurrent hepatitis C in liver allografts - Prospective assessment of diagnostic accuracy, identification of pitfalls, and observations about pathogenesis

AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2004 MAY; 28 (5): 658-669

998

2780 Ansari MJI, Sayegh MH

Clinical transplantation tolerance: The promise and challenges

KIDNEY INTERNATIONAL. 2004 MAY; 65 (5): 1560-1563

999

2807 Utter GH, Owings JT, Lee TH, Paglieroni TG, Reed WF, et al.

Blood transfusion is associated with donor leukocyte microchimerism in trauma patients

JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE. 2004 OCT; 57 (4): 702-707

1000

2834 Bond GJ, Mazariegos GV, Sindhi R, Abu-Elmagd KM, Reyes J

Evolutionary experience with immunosuppression in pediatric intestinal transplantation

JOURNAL OF PEDIATRIC SURGERY. 2005 JAN; 40 (1): 274-279

The Kidney Transplant Papers 9 papers representing Starzl's ground breaking work in the area of kidney transplantation. And all the papers citing them from the SCI, AHCI, SSCI databases up-to-date as of May 2012	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 17722, GCS 106366, CR 136943 Collection span: 1963 - 2012
List of All Records